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Summary 
Despite extensive evidence for its effectiveness, ECT remains the subject of fierce opposition 
from those contesting its benefits and claiming extreme harms. Alongside some reflections on 
my experiences of this treatment, I examine the case against ECT, and find that it appears to 
rest primarily on unsubstantiated claims about major ethical violations, rather than clinical 
factors such as effectiveness and risk. 
Keywords 
Electroconvulsive therapy (ECT); depression; bipolar disorder; lived experience; ethics; involuntary 
treatment. 
Introduction 
A recent review discussing the efficacy and safety of modern electroconvulsive therapy (ECT) finds 
that it is still the “most effective treatment for severe, psychotic or treatment-resistant depression” (1). 
While ECT is viewed by many clinicians and recipients as indispensable in treating debilitating and 
“life-threatening” severe mental illness (2,3), it nevertheless remains, arguably, the most stigmatised, 
misunderstood, contested, and feared psychiatric or perhaps even medical, treatment. A few days after 
publication of the review, a short and sensationalist newspaper article, “Shock Tactics” (4), directed 
anyone “considering having a big electric shock passed through your brain” towards a Psychology 
Today article by an influential academic ECT-opponent, disputing efficacy and calling for urgent review 
of a treatment with “risks of brain damage and death” (5). As a researcher focusing on medical ethics 
and law, but also someone with considerable lived experience of receiving ECT, my aim here is to 
examine the nature and validity of the extreme and often vitriolic opposition to this treatment.  
Probably the strongest feeling engendered by the notion of ECT is fear. ECT involves an electrical 
charge being passed through the brain to induce a seizure and cause a radical shift of mental state.  
Perhaps unsurprisingly, this description itself might sound alien, scientistic, and frightening. Added to 
this are multiple cultural and media representations situating ECT firmly within the ‘dark side’ of 
psychiatry (6,7). Most well-known is the iconic 1975 film, One Flew Over the Cuckoo’s Nest, 
portraying psychiatry as a misused tool of repressive social control. Jack Nicholson’s character, who is 
not mentally unwell, forcibly receives ECT, without anaesthetic, as punishment for insubordinate 
behaviour. The effects of this treatment can become easily conflated with the gruelling final scene 
showing Nicholson’s near-vegetative state, resulting from a psycho-surgical procedure not shown and 
no longer practised. The takeaway impression of ECT is as a sadistic and illegitimate process, punitive 
rather than therapeutic, and capable of, effectively, destroying the brain. No famous depictions of ECT 
within contemporary psychiatric practice exist to counter these images, demonstrating the severity of 
the conditions it treats and its potential benefits. No wonder that ECT remains an object of fear. Yet, 
for myself, as for many others for whom ECT has been a life-saving treatment, the greatest fear 
surrounding ECT is that it might one day be inaccessible or abolished. 
Before examining the anti-ECT position, I present some potential “conflict of interests” alongside some 
credentials for my ability to offer a balanced view about psychiatric practice, ethics, and law. For me, 
personally, the benefits of ECT have been immeasurable in treating a severe and dangerous mixed-
affective presentation of bipolar disorder, which remained, until very recently, steadfastly resistant to 
any acute or maintenance psychopharmacological treatment or psychotherapeutic intervention. I first 
received ECT aged 21, after over a year of failed treatments and hospitalisations. Eight bi-weekly ECT 
treatments were for myself and my family the ‘miracle cure’ allowing me to reengage with life and 
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return to University to complete my degree.  Treatment was not frightening, and I experienced no 
significant side effects.  Despite receiving over 150 ECT treatments over the years, I have noticed no 
deterioration of intellectual ability or capacity to build new memories and have been able successfully 
to resume my academic career.  I was also on the Royal College of Psychiatrist’s ECT Accreditation 
Service advisory committee for 6 years.  
However, my experience and views of ECT and psychiatry are not universally positive. I have sustained 
considerable autobiographical memory loss from later treatments, causing both psychological and 
practical difficulties, and would never minimise or deny the views of those for whom side effects have 
been severe and debilitating. While I myself, when well, condone and accept the need for a treatment I 
often resist while unwell, amongst my many experiences of ECT were instances where treatment and 
enforcement were mismanaged. More generally, my own academic work often involves critique of 
contemporary psychiatry and mental health law.  
The case against ECT 
The case for suspension or abolition of ECT is usually argued in terms of three main clinical 
transgressions: lack of evidence for effectiveness; minimisation or even denial of severe side effects; 
treatment without informed consent. However, close examination suggests that ethical rather than 
clinical concerns dominate anti-ECT critiques. A pervasive One Flew Over the Cuckoo’s Nest-type 
image emerges of deliberate concealment and human rights violations. 
Claim 1 – lack of evidence for effectiveness. 
A 2020 review by prominent ECT critics concludes “There is no evidence that ECT is effective for… 
its target diagnostic group—severely depressed people, or for suicidal people, people who have 
unsuccessfully tried other treatments first, involuntary patients, or children and adolescents” (8). Such 
claims, common within anti-ECT literature  (9,10), seem strange and are easily challenged, given 
considerable evidence and abundant patient and clinical testimonies to major benefits (1,3,11-15), 
including many calling for ECT’s use not to be restricted to ‘last resort’ treatment (1,3,11,12,15). 
Research on ECT’s effectiveness is too extensive to summarise or assess here. The critical 2020 review 
only considered studies between 1956 and 1985, with many of its findings highly disputable, 
particularly in a modern context (15). These points aside, however, let us consider the broader 
implications of this anti-ECT viewpoint.  
The first question must surely be motivation. Around 1.4 million people worldwide receive ECT 
annually (1). In psychiatric terms, ECT is relatively costly and complex, in most countries involving 
general anaesthesia, with estimates of annual treatment costs which “can exceed $10 000” (14).  If, after 
80 years of ECT, there really was no evidence for effectiveness, why would healthcare providers 
continue funding ECT and what would psychiatrists stand to gain, especially in the face of such 
acrimonious criticism?  
Moreover, claiming that psychiatry knowingly inflicts an invasive medical treatment with potentially 
serious side effects and no evidence of substantive therapeutic benefits implies a global breach of core 
medical ethical principles. Not only would this violate both beneficence and nonmaleficence, but 
seemingly also justice, through allocating limited resources to expensive and ineffective treatments. 
Moreover, deliberately misleading patients about therapeutic benefits would surely negate ‘informed’ 
consent and autonomous decision-making concerning treatment. While psychiatry may sometimes 
involve errors of clinical judgement, the idea that so many medical practitioners are complicit in 
breaching fundamental professional ethics seems implausible and devoid of apparent motivation.  
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Claim 2 – minimisation or even denial of severe side effects. 
ECT opponents claim that psychiatry fails to acknowledge the extent, severity, or even existence of 
severe potential side effects from ECT, including “brain damage”, “mortality”, and “traumatic impact 
on the brain” (10). However, as with lack of effectiveness, claims that ECT has such side effects, which 
are deliberately and collectively concealed, denied, or minimised by psychiatrists, once again implies 
multiple seemingly implausible and unmotivated ethical violations.  
It is widely acknowledged that ECT’s most substantial side effect can be “retrospective 
autobiographical memory” loss and the substantial research exploring ways to reduce retrograde 
amnesia indicates, very clearly, that psychiatry is neither ignoring nor denying this issue  (1,16,17).  
Historically, this phenomenon was underacknowledged or even denied (16) and some clinicians, as I 
myself have witnessed, may still fail to attribute sufficient weight to its nature and impact. While 
guidance materials and clinical decision-making now usually include consideration and information 
about such side effects, a desire to emphasise potential benefits may lead to insufficient attention being 
devoted to issues surrounding retrograde amnesia. For example, the new Royal College of Psychiatrists 
ECT information leaflet mentions the possibility of “permanent” gaps under “Short-term” rather than 
“Long-term” side effects (18). Assessing memory issues is further complicated by the difficulties of 
differentiating residual cognitive impairment resulting from depression from the effects of ECT, which 
can itself help to relieve these impairments (19).  
I have, myself, experienced such memory loss within two perinatal periods. For various reasons, I have 
twice needed multiple courses of bi-weekly and bilateral ECT within a period of three to four years. 
Such extensive treatment is unusual and may make my experience of memory loss greater than usual 
(16). My lasting memory loss relating to people, events, and periods of my life can be difficult both 
emotionally and practically. I have found various ways to manage this amnesia and am extremely 
fortunate to have support from multiple people who understand and help to fill in the gaps. For myself 
and many others (3), although not for everyone, benefits of treatment have undoubtedly outweighed 
these costs. Beyond these autobiographical memory gaps, however, no clinical evidence supports 
common accusations of permanent ‘brain damage’, physical damage, or major fatality risk 
(1,5,9,10,12,22).  
Claim 3 – excessive use of involuntary treatment.  
A final major concern is the proportion of patients receiving ECT without providing informed consent, 
usually described by ECT opponents using language implying physical coercion (8). Informed consent 
will, of course, always be contentious in relation to psychiatry, given common international use of 
legally sanctioned involuntary treatment. The United Nations Committee on the Rights of Persons with 
Disabilities, for example, call for abolition of all involuntary treatment (General Comment 1). Yet, with 
ECT, such concerns appear to extend beyond straightforward questions about ethical validity of 
involuntary treatment.   
Multiple factors might justify administering ECT using statutory measures to allow treatment without 
informed consent. ECT is increasingly used for severe, life-threatening depression, and treatment-
resistant illness, often including psychotic features, catatonia, or prolonged mania. Given probable 
severity of symptoms and concomitant likelihood of impaired decision-making abilities or extreme risk, 
informed consent may well not be possible (23,24). In such cases failure to use statutory provision 
authorising substitute decision-making would itself be unethical, and safeguards surrounding 
involuntary use of ECT within mental health legislation are typically more stringent than for other forms 
of treatment. Although the type of physical coercion suggested by ECT critics is not typically involved, 
such cases would be classified as ‘involuntary’, and a recent dataset from UK clinics reports that 46.7% 
of patients were formally detained when starting acute ECT treatment, with 41% lacking decision-
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making capacity to consent to treatment (25).  However, there has been a well-documented and alarming 
rise in the use of formal detention in England and Wales, with a national report showing that, by 2016/7, 
80% of adult psychiatric inpatients and 100% of older inpatients (65+) were formally detained in some 
areas (26). By comparison figures for ECT might even be seen as relatively low given that detention 
figures amongst acute ECT patients suggest that over half of ECT recipients received treatment having 
provided informed consent, even though it is likely that the majority were inpatients (18) ,. Moreover, 
evidence suggests that patients often regain capacity to consent during a course of ECT and consent to 
further treatment (23,25), with many involuntary patients retrospectively assessing treatment as helpful  
(23,27), an experience which I myself have shared. 
Cost-benefit analysis: which factors are often omitted by the anti-ECT lobby? 
Accusations of ethical violations through ineffective treatment, concealed side effects, and excessive 
involuntary treatment seem unconvincing.  Moreover, while treatment decisions involve informed cost-
benefit analysis (1,3,16), ECT opponents often deemphasise, omit, or even misrepresent details about 
the treatment process and conditions treated, despite their frequent accusations of obfuscation and 
concealment amongst ECT practitioners. 
In almost all countries, ECT now involves general anaesthesia and a muscle relaxant to prevent major 
physical convulsion (1,3). In the UK, for example, ECT staff are trained to answer any questions or 
concerns, provide calming environments both pre- and post-treatment, and conduct physical and 
cognitive checks (28). For me, when severely unwell, my fears concerning ECT stem entirely from 
persecutory delusions about “brain-control”, rather than fear of the physical process itself. Most 
importantly, perhaps, ECT opponents rarely describe the realities of conditions treated by ECT, 
Unfortunately, terminology used to defend ECT, such as ‘debilitating’, ‘depression’, or even ‘life-
threatening’, barely evokes the experience of severe affective disorders or their potential consequences.  
Though hard to articulate, I offer some personal examples to try to demonstrate the lived experience 
and dangers of such conditions and reasons for prescribing ECT. When becoming severely unwell, I 
suddenly enter an internal world utterly detached from everything and everyone around me. The US 
psychiatrist Jamison’s description of her own mixed affective state prior to attempting suicide has 
always resonated deeply - her mind a “murderous cauldron” her body “uninhabitable”, “raging and 
weeping and full of destruction and wild energy gone amok”  (29). For me, “tortuous energy” is 
underpinned by manic grandiosity and invincibility, with intermittent euphoria pushing me towards 
enlightenment, but accompanied by terrifying paranoia. This lethal combination is all the more 
dangerous, usually veiled under a deceptive presentation of calm lucidity.  
During the final trimester of my second pregnancy, I descended rapidly into these familiar patterns. I 
clearly needed ECT, although I did not want this or any other treatment. Why was this? I was bombarded 
by thoughts, voices, and signs telling me that my psychiatrist, whom I deeply trust and respect, was 
masterminding a conspiracy to control my mind and prevent me from fulfilling my destiny, making any 
treatment compliance an act of cowardly capitulation. Nevertheless, like Jamison (29), I had written 
advance documentation, requesting ECT, administered involuntarily if necessary, if I became severely 
unwell. In fact, the perinatal risks associated with bipolar disorder and my reliance on ECT are so great 
that my decision to try for a second child had been heavily contingent on the availability of ECT in the 
perinatal period.  
The literature on ECT in pregnancy is, understandably, limited, but points towards its safety and 
effectiveness (11,12,30). I received 12 bi-weekly treatments during the last trimester of pregnancy. 
Treatment took place in the main theatres, with a midwife and obstetric team present, along with full 
foetal monitoring and provision for emergency delivery. The ECT team were incredible and took me 
through the process with great compassion, acknowledging and doing everything possible to help me 
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manage my fear. After the 10th treatment, during the 36th week of pregnancy, there was a sudden and 
dramatic remission of the severe symptoms and psychosis. Just as rapidly as reality had vanished, it 
returned. The last treatment was at 38 weeks, and I gave birth to a healthy child 2 weeks later, who 
started school this year. 
Conclusion 
On examination, academic opposition to ECT appears generally to rest on unsubstantiated claims of 
ethical violations, some of which its opponents themselves may even perpetrate. Opposition comprises 
a small but vocal cohort, mainly subscribing to an ideological agenda rarely mentioned within 
specifically anti-ECT literature (11,15), rejecting any medical understanding of mental illness and 
frequently questioning psychiatric motives. The critical 2020 review appears within the official journal 
of an international society centred on the premise that mental illnesses “should not be considered 
medical problems and traditional medical treatment is not a solution” (https://psychintegrity.org ) (8). 
Very similar views are espoused, for example, on other sites hosting anti-ECT literature such as 
‘Behaviourism and Mental Health’ and the ‘Council for Evidence-based Psychiatry’ (http://cepuk.org/ 
). 
Based on prejudicial and unjustified assumptions about the intrinsic illegitimacy and immorality of 
psychiatry, many anti-ECT academics simply assume a lack of credibility in the evidence and 
testimonies presented by psychiatrists. Similar assumptions about intrinsic vulnerabilities or credulity 
lead to dismissal or even discrimination against ECT advocates who, like myself, claim to have 
benefited from the treatment. As Dukakis writes in a thoughtful collection of testimonies from those 
who have benefited from ECT, including her own: “I fully expect to be attacked. I feel like I am putting 
a target on my back for ECT’s many critics” (3). Moreover, the views and utter intransigence of calls 
for suspension or abolition of ECT take no account of potential harms from depriving those helped by 
ECT treatment and deterring those who are severely unwell from considering treatment which could 
help to relieve their suffering.     
Public perceptions of ECT may well still be dominated by a One Flew Over the Cuckoo’s Nest image. 
Currently, the sensationalist and flawed views of the academic anti-ECT lobby continue to bolster such 
damaging and unjustified public perceptions and media discussion, rendering it unlikely that any 
supporting evidence for ECT will ever receive balanced consideration. No matter how much evidence 
is presented in journals, unless psychiatry is proactive in educating people about ECT and is helped, 
rather than hindered, by the media, ECT’s ‘image problem’ will persist. The stigma surrounding ECT 
means “that its use is severely limited, and its merits are neglected or even denied” (11), with even those 
psychiatrists who recognise its effectiveness deterred from prescribing ECT and training others (3).   
My arguments are in no way intended to deny any historic or even contemporary instances of misuse 
(11), or to negate the views of service users who have experienced harm from ECT, either without any 
benefits, or with benefits which cannot outweigh the damage. However, any rights-based approach must 
surely recognise the rights of individuals to conduct their own cost-benefit analysis and to have available 
to them a treatment with the potential to alleviate severely debilitating and dangerous symptoms (3,11).  
From a personal perspective, ECT does not cure bipolar disorder and the condition is for me, as for so 
many others, an ongoing challenge. I am incredibly lucky to have levels of social, clinical, and material 
support unavailable to many. I am aware of the high probability that I may one day become severely 
unwell again. I am also aware that, if I do, I will need ECT and, when I receive the first treatments, 
there may well be some element of coercion, whether formal or informal. Almost certainly, I will 
experience some degree of memory loss. But today I am alive. I have two happy and healthy daughters 
and am able to perform a job which is both deeply stimulating and rewarding. Only a few years ago 
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many, if not all, of these things would have seemed highly improbable. Without ECT, it is almost certain 
that they would not have happened. 
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